TRIO PHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 36499281
Vermlandsgade 51, 2300 København S
info@triopharma.dk
tel: 53843103
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Other operating income | 39.50 | 123.32 | |||
Gross profit | 84.55 | 360.56 | 11 576.86 | - 491.39 | - 288.58 |
Employee benefit expenses | - 423.99 | - 482.75 | - 336.24 | - 370.88 | - 539.30 |
Other operating expenses | -6.00 | ||||
Total depreciation | -4.51 | -9.02 | |||
EBIT | - 339.44 | - 122.19 | 11 240.62 | - 868.27 | - 827.88 |
Other financial income | 0.07 | 0.04 | 0.07 | 4.09 | |
Other financial expenses | -21.99 | -29.67 | -40.89 | -21.16 | -48.01 |
Pre-tax profit | - 361.43 | - 151.78 | 11 199.77 | - 889.36 | - 871.80 |
Income taxes | -2 180.21 | 382.13 | |||
Net earnings | - 361.43 | - 151.78 | 9 019.56 | - 889.36 | - 489.66 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Machinery and equipment | 40.57 | ||||
Tangible assets total | 40.57 | ||||
Other receivables | 5.16 | 5.97 | 5.97 | ||
Investments total | 5.16 | 5.97 | 5.97 | ||
Non-current other receivables | 4.60 | 4.79 | |||
Long term receivables total | 4.60 | 4.79 | |||
Finished products/goods | 101.39 | 135.29 | 502.24 | 732.00 | |
Inventories total | 101.39 | 135.29 | 502.24 | 732.00 | |
Current trade debtors | 52.81 | 0.84 | 33.65 | 113.65 | |
Prepayments and accrued income | 12.06 | 12.06 | 12.06 | 2.64 | 3.92 |
Current other receivables | 147.46 | 77.41 | 28.72 | 33.88 | 20.73 |
Current deferred tax assets | 35.18 | 35.18 | 383.00 | ||
Short term receivables total | 159.53 | 142.29 | 76.79 | 105.34 | 521.30 |
Cash and bank deposits | 15.29 | 18.20 | 158.82 | 282.30 | 37.15 |
Cash and cash equivalents | 15.29 | 18.20 | 158.82 | 282.30 | 37.15 |
Balance sheet total (assets) | 321.38 | 300.57 | 240.78 | 895.85 | 1 296.42 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
Retained earnings | - 799.98 | -1 161.41 | -9 113.19 | -93.63 | - 982.99 |
Profit of the financial year | - 361.43 | - 151.78 | 9 019.56 | - 889.36 | - 489.66 |
Shareholders equity total | -1 111.41 | -1 263.19 | -43.63 | - 932.99 | -1 422.65 |
Provisions | 0.86 | ||||
Non-current liabilities total | |||||
Current trade creditors | 306.32 | 131.94 | 15.38 | 44.53 | 25.00 |
Current owed to group member | 253.99 | 1 772.63 | 2 681.00 | ||
Other non-interest bearing current liabilities | 1 126.47 | 1 431.82 | 15.05 | 11.68 | 12.22 |
Current liabilities total | 1 432.79 | 1 563.77 | 284.41 | 1 828.84 | 2 718.21 |
Balance sheet total (liabilities) | 321.38 | 300.57 | 240.78 | 895.85 | 1 296.42 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.